This report shows public data only. Is this your organisation? If so, login here to view your full report.


PRI reporting framework 2017

You are in Direct - Listed Equity Active Ownership » (Proxy) voting and shareholder resolutions

(Proxy) voting and shareholder resolutions


LEA 17. Voting policy & approach

New selection options have been added to this indicator. Please review your prefilled responses carefully.

17.1. Indicate whether your organisation has a formal voting policy.

17.2. Indicate what your voting policy covers:

17.4. Provide a brief overview of your organization’s approach to (proxy) voting.

Our voting policy in embedded in the legal disclaimer. We are currently in the process of review our voting rights policy.

As an active and responsible shareholder, Mirabaud believes that voting at shareholder meetings is a key moment for taking part in companies' decision-making. This is why Mirabaud has pledged to vote uniformly at shareholder meetings of all companies, regardless of the nationality of issuing companies, as long as the issuer provides sufficient information and as long as its custodians are able to take its votes into account.

As such, Mirabaud exercises its shareholder’s rights through a third-party proxy voting specialist firm, Institutional Shareholder Services Europe S.A. (ISS). ISS carries out analysis on the companies in which the funds/mandates invest and makes voting suggestions while taking into account the approach defined by Mirabaud with ISS. If Portfolio Managers (PMs) decide to vote against ISS’ recommendations, they must justify its stance. Under no circumstances ISS replaces Mirabaud PMs, who alone shall decide how to vote, in the sole interests of unit holders in their portfolios (funds and/or mandates).

17.5. Provide an overview of how you ensure your voting policy is adhered to, giving details of your approach when exceptions to the policy are made (if applicable).

The voting rights are, in principle, exercised according to the recommendations of ISS. A particular care is giving to “meaningful” events such as merger proposals, liquidations, or spin-offs, which could have a notable effect on the organisation of the company in question, its value or the rights attached to the shares held.

Portfolio Managers (PMs) have the possibility at any time, prior to the deadline for the validation on the instructions, to derogate from the recommendation issued by ISS. However, they must motivated their decision in front of a committee composed of executive management representative, whose purpose is to validate the voting decision.


LEA 18. Typical approach to (proxy) voting decisions

18.1. Indicate how you typically make your (proxy) voting decisions.


Based on

18.2. Additional information.[Optional]

LEA 19. Percentage of voting recommendations reviewed

New selection options have been added to this indicator. Please review your prefilled responses carefully.

19.1. Of the voting recommendations that your service provider made in the reporting year, indicate the percentage reviewed by your organisation, giving reasons.

Percentage of voting recommendations your organisation reviewed

Reasons for review

19.2. Additional information [Optional]

LEA 20. Confirmation of votes (Private)

LEA 21. Securities lending programme

New selection options have been added to this indicator. Please review your prefilled responses carefully.

21.1. Indicate if your organisation has a securities lending programme.

21.3. Additional information.

          No securities lending is currently authorised by Mirabaud Asset Management.

LEA 22. Informing companies of the rationale of abstaining/voting against management

New selection options have been added to this indicator. Please review your prefilled responses carefully.

22.1. Indicate whether you or the service providers acting on your behalf raise any concerns with companies ahead of voting

22.2. Indicate whether you and/or the service provider(s) acting on your behalf, communicate the rationale to companies, when , you abstain or vote against management recommendations.

22.3. Additional information. [Optional]

Outputs and outcomes

LEA 23. Percentage of (proxy) votes cast

23.1. For listed equities where you and/or your service provider have the mandate to issue (proxy) voting instructions, indicate the percentage of votes cast during the reporting year.

Votes cast (to the nearest 1%)

98 %

Specify the basis on which this percentage is calculated

23.2. Explain your reason(s) for not voting certain holdings

23.3. Additional information. [Optional]

LEA 24. Proportion of ballot items that were for/against/abstentions

24.1. Indicate if you track the voting instructions that you and/or your service provider on your behalf have issued.

24.2. Of the voting instructions that you and/or third parties on your behalf issued, indicate the proportion of ballot items that were:

Voting instructions
Breakdown as percentage of votes cast
For (supporting) management recommendations
86 %
Against (opposing) management recommendations
14 %
0 %

24.3. Describe the actions you take after voting against management recommendations.

          We keep discussing with the company on those topics during our engagement meetings/calls.

24.4. Additional information. [Optional]

LEA 25. Shareholder resolutions

New selection options have been added to this indicator. Please review your prefilled responses carefully.

25.1. Indicate if your organisation directly or via a service provider filed or co-filed any ESG shareholder resolutions during the reporting year.

25.6. Additional information. [Optional]

LEA 26. Examples of (proxy) voting activities (Not Completed)


LEA 27. Disclosing voting activities

27.1. Indicate if your organisation proactively discloses information on your voting activities.

27.5. Indicate the voting information your organisation proactively discloses to clients/beneficiaries.

Indicate how much of your voting record you disclose

Indicate what level of explanation you provide

27.6. Indicate how frequently you report voting information.

27.8. Additional information. [Optional]